Sentrachem Limited v A L Terreblanche

Mr Terreblanche was a member of the Sentrachem Group Pension Fund. During 2010, the pension fund received approval for a surplus apportionment scheme under the Pension Funds Act 24 of 1956. On 6 October 2010, the pension fund made a payment of R94,614.99 to Mr Terreblanche. On the same day, the pension fund made a second erroneous payment to Mr Terreblanche in the sum of R453,872.31, made in the mistaken belief that this amount was due to him as his share of the surplus apportionment scheme. On 27 October 2010, Mr Andrew, tasked with investigating double payments, discovered the erroneous payment. The pension fund issued summons served on Mr Terreblanche on 22 August 2011 claiming R453,872.31 based on the condictio indebiti. On 13 December 2011, the Registrar of Pension Funds approved the voluntary dissolution of the pension fund and Mr Andrew was substituted as plaintiff on 27 February 2012. On 27 September 2013, Mr Andrew entered into a cession and assignment agreement with Sentrachem, ceding the claim against Mr Terreblanche. On 22 November 2013, Sentrachem was substituted as plaintiff, with the formal substitution occurring on 3 December 2013. Mr Terreblanche did not object to either substitution. On 31 March 2015, Mr Terreblanche raised a special plea of prescription, arguing that the claim prescribed on 26 October 2013 (three years from 27 October 2010), before Sentrachem's substitution.

• Whether the substitution of a party after litis contestatio as a result of the cession of a debt gives rise to a valid plea of prescription
• Whether the cessionary (Sentrachem) acquired locus standi to pursue the claim in its own name
• Whether the cessionary was impoverished for purposes of the condictio indebiti claim
• The effect of the Prescription Act 68 of 1969, particularly sections 11(d) and 15, on the substitution of a plaintiff pursuant to a cession after litis contestatio

1. The appeal was upheld with costs. 2. The order of the court a quo was set aside and substituted with: (a) The defendant's special plea of prescription is dismissed with costs; (b) The defendant is ordered to pay the plaintiff the sum of R453,972.31; (c) The defendant is ordered to pay the plaintiff interest on the sum of R453,972.31 at the rate of 15.5% per annum calculated from 11 July 2011 to date of payment in full; (d) The defendant must pay the costs of the action including all reserved costs.

The binding legal principles established are: (1) The substitution of a party after litis contestatio as a result of the cession of a debt does not give rise to a valid plea of prescription. (2) The Prescription Act 68 of 1969 prescribes periods of prescription in respect of 'debts', not causes of action. Even where substitution of a plaintiff amounts to the introduction of a new cause of action, the debt remains the same. (3) When substitution pursuant to a cession occurs, the cessionary acquires by way of cession all rights and obligations vested in the cedent at the time of substitution. (4) The original interruption of prescription by the timeous service of summons is not affected by a subsequent cession or amendment to substitute a plaintiff. The amendment is a mere procedural step to effect the substitution. (5) The process under which the debt is being pursued remains the same throughout. Only the identity of the party pursuing the debt changes; the debt itself remains unaltered and unaffected by prescription. (6) A cessionary has full locus standi to pursue a claim in its own name once an order for substitution has been made. (7) Upon a valid cession, the underlying obligation and the personal right flowing from it remain unchanged, transferring with all sureties, real securities, advantages and disadvantages attached to it. Impoverishment in an enrichment claim therefore transfers to the cessionary.

The court made the following non-binding observations: (1) If prescription was a valid defence to a substitution, it should have been raised in opposition to the substitution application itself. Mr Terreblanche's failure to object to the substitution amounted to consent to such substitution. (2) The court distinguished Standard General Insurance Co Ltd v Eli Lilly (SA) (Pty) Ltd 1996 (1) SA 382 (W) on the factual basis that in that case, the creditor of the debt did not originally claim payment of the debt and the notice of the application for amendment to substitute the plaintiff had been given more than three years after the debt became due. The reliance on that decision by the court a quo was therefore misplaced. (3) The court noted that the issue regarding the computation of the first amount paid to Mr Terreblanche did not affect the resolution of the main issues in the appeal.

This case is significant in South African law as it clarifies important principles relating to prescription, cession, and substitution of parties in civil proceedings. It establishes that the substitution of a plaintiff pursuant to a cession after litis contestatio does not constitute the institution of new proceedings for purposes of prescription. The case reinforces that the Prescription Act operates in respect of 'debts', not causes of action, and that the identity of the creditor may change without affecting the running of prescription where the underlying debt remains the same. The judgment provides clarity on the effect of cession on the rights of cessionaries, including their locus standi and entitlement to step into the cedent's shoes with all rights and obligations intact. It also clarifies that impoverishment in enrichment claims transfers to the cessionary upon cession. The case is important for pension fund litigation, debt recovery, and the practical application of the Prescription Act in cases involving cession and substitution of parties.